Does maintenance therapy with thalidomide benefit patients with multiple myeloma?

被引：0
|
作者：
Nikhil C Munshi
Constantine S Mitsiades
Paul G Richardson
Kenneth C Anderson
机构：
[1] NC Munshi is the Associate Director of the Jerome Lipper Multiple Myeloma Center (JLMMC) at the Dana-Farber Cancer Institute (DFCI),Chief of Division of Hematologic Neoplasia at DFCI and the Kraft Family Professor of Medicine at HMS
[2] Physician at Boston VA Healthcare System and Associate Professor of Medicine at Harvard Medical School (HMS),undefined
[3] CS Mitsiades is Instructor in Medicine at and Associate Professor of Medicine at HMS,undefined
[4] PG Richardson is the Clinical Director of the JLMMC at the DFCI,undefined
[5] and KC Anderson is the Director of the JLMMC,undefined
[6] all in Boston,undefined
[7] MA,undefined
[8] USA.,undefined
来源：
Nature Clinical Practice Oncology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：394 / 395
页数：1
相关论文
共 50 条
  • [41] Maintenance therapy in multiple myeloma
    Harousseau, Jean-Luc
    [J]. HEMATOLOGY REPORTS, 2009, 1 (02) : 65 - 69
  • [42] Thalidomide therapy and polyneuropathy in myeloma patients
    Laaksonen, S
    Remes, K
    Koskela, K
    Voipio-Pulkki, LM
    Falck, B
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2005, 10 : 48 - 49
  • [43] Thalidomide as maintenance therapy following double cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma
    Pratico, G.
    Martino, M.
    Console, G.
    Irrera, G.
    Mesina, G.
    Callea, V
    Stelitano, C.
    Molica, S.
    Morabito, F.
    Piro, E.
    Quartarone, E.
    Musolino, C.
    Mamone, D.
    Iacopino, P.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI57 - XI57
  • [44] Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma
    Ludwig, Heinz
    Poenisch, Wolfram
    Knop, Stefan
    Egle, Alexander
    Schreder, Martin
    Lechner, Daniel
    Hajek, Roman
    Gunsilius, Eberhard
    Krenosz, Karl Jochen
    Petzer, Andreas
    Weisel, Katja
    Niederwieser, Dietger
    Einsele, Hermann
    Willenbacher, Wolfgang
    Melchardt, Thomas
    Greil, Richard
    Zojer, Niklas
    [J]. BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 751 - 757
  • [45] Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation
    Aznab, Mozaffar
    Rezaei, Mansour
    Navabi, Jafar
    Moieni, Ali
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (02) : E138 - E143
  • [46] MAINTENANCE THERAPY IN MYELOMA - RISK VERSUS BENEFIT
    JACOBS, P
    DUBOVSKY, D
    KING, HS
    [J]. BRITISH MEDICAL JOURNAL, 1975, 3 (5981): : 490 - 490
  • [47] Bortezomib-Dexamethasone or Vincristine-Doxorubicin-Dexamethasone as Induction Therapy Followed by Thalidomide as Maintenance Therapy in Untreated Multiple Myeloma Patients
    Chen, R. A.
    Tu, Y.
    Cao, Y.
    Liu, L.
    Liang, Y.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (05) : 1975 - 1984
  • [48] MAINTENANCE THERAPY IN MYELOMA - RISK VERSUS BENEFIT
    SIEBER, SM
    ADAMSON, RH
    [J]. BRITISH MEDICAL JOURNAL, 1975, 2 (5970): : 557 - 557
  • [49] Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study
    Feyler, Sylvia
    Rawstron, Andy
    Jackson, Graham
    Snowden, John A.
    Cocks, Kim
    Johnson, Roderick J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (03) : 429 - 433
  • [50] Thalidomide maintenance following high dose therapy in multiple myeloma: A UK myeloma forum phase 2 study.
    Feyler, S
    Jackson, G
    Rawstron, A
    El-Sherbiny, YM
    Snowden, JA
    Johnson, RJ
    [J]. BLOOD, 2003, 102 (11) : 691A - 691A
12345